Reprogramming of tumor-associated macrophages by targeting β-catenin/FOSL2/ARID5A signaling: A potential treatment of lung cancer

Journal: Science Advances

Published: 2020-06-01

DOI: 10.1126/sciadv.aaz6105

Affiliations: 13

Authors: 15

Go to article
Institutions Share
The German Center for Lung Research (DZL), Germany 0.32
Max Planck Institute for Heart and Lung Research (MPI-HLR), Germany 0.21
Cluster of Excellence - The Cardio-Pulmonary Institute (CPI), Germany 0.12
Institute of Biochemistry I, GU, Germany 0.10
Faculty of Medicine (FB11), JLU, Germany 0.09
Laboratory for Molecular Respiratory Carcinogenesis (LMRC), University of Patras, Greece 0.04
Institute of Lung Biology and Disease (iLBD), CPC-M, Germany 0.04
Frankfurt Cancer Institute (FCI), Germany 0.04
Institute for Molecular Oncology (IMO), Uni Marburg, Germany 0.03

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER